Literature DB >> 27795480

Poliovirus Studies during the Endgame of the Polio Eradication Program.

Minetaro Arita1.   

Abstract

Since the beginning of Global Polio Eradication Initiative in 1988, poliomyelitis cases caused by wild poliovirus (PV) have been drastically reduced, with only 74 cases reported in 2 endemic countries in 2015. The current limited PV transmission suggests that we are in the endgame of the polio eradication program. However, specific challenges have emerged in the endgame, including tight budget, switching of the vaccines, and changes in biorisk management of PV. To overcome these challenges, several PV studies have been implemented in the eradication program. Some of the responses to the emerging challenges in the polio endgame might be valuable in other infectious diseases eradication programs. Here, I will review challenges that confront the polio eradication program and current research to address these challenges.

Entities:  

Mesh:

Year:  2016        PMID: 27795480     DOI: 10.7883/yoken.JJID.2016.356

Source DB:  PubMed          Journal:  Jpn J Infect Dis        ISSN: 1344-6304            Impact factor:   1.362


  4 in total

Review 1.  Biosafety and Biosecurity in European Containment Level 3 Laboratories: Focus on French Recent Progress and Essential Requirements.

Authors:  Boris Pastorino; Xavier de Lamballerie; Rémi Charrel
Journal:  Front Public Health       Date:  2017-05-31

Review 2.  Polio endgame risks and the possibility of restarting the use of oral poliovirus vaccine.

Authors:  Radboud J Duintjer Tebbens; Kimberly M Thompson
Journal:  Expert Rev Vaccines       Date:  2018-08-09       Impact factor: 5.217

Review 3.  The interplay of autophagy and enterovirus.

Authors:  Lihong Huang; Jianbo Yue
Journal:  Semin Cell Dev Biol       Date:  2019-09-25       Impact factor: 7.727

4.  The experiences of using polio outbreak simulation exercises to strengthen national outbreaks preparedness and response plans in sub-Saharan Africa.

Authors:  Daudi Manyanga; Brine Masvikeni; Fussum Daniel
Journal:  Pan Afr Med J       Date:  2020-08-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.